Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. (SNDX) — Form 144: Proposed sale of shares
About this filing
Syndax Pharmaceuticals, Inc. (SNDX) filed Form 144 (proposed sale of shares) with the SEC on Oct 29, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- DENNIS G PODLESAK
- Relationship
- Director
- Shares to sell
- 8,000
- Market value
- $114,560.00
- Approximate sale date
- Oct 29, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Oct 29, 2026 · Exercise of Stock Options
Rule 10b5-1 plan · adopted Dec 15, 2025
More SNDX filings
- 4
Filed Oct 30, 2026
- SC 13G
Filed Aug 7, 2026
- 10-Q
Filed Aug 4, 2026
- 8-K
Filed Aug 4, 2026
- 8-K
Filed Jul 14, 2026
- 4
Filed Jul 9, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.